https://www.selleckchem.com/products/ml351.html
A novel variant of c.4010delT in DYSF was identified in this case, which broadens the genetic spectrum of LGMD2B. We systematically evaluated the evidences on oncological and functional outcomes of high-intensity focused ultrasound (HIFU) as the primary treatment for localized prostate cancer (PCa). A systematic review was used Medline, Embase, and the Cochrane Library from the inception of each database. The review analyzed the oncological and functional outcomes of HIFU in the treatment of PCa. The RevMan 5.3 software was used for quant
Like
Comment
Share
